Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Roller A"'
Autor:
Miguel Hage Amaro, Aaron Brock Roller
Publikováno v:
Arquivos Brasileiros de Oftalmologia, Vol 75, Iss 4, Pp 273-276 (2012)
Arquivos Brasileiros de Oftalmologia v.75 n.4 2012
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia v.75 n.4 2012
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
PURPOSE: To report the response of choroidal neovascularization to intravitreal ranibizumab or bevacizumab treatment in the setting of age-related macular degeneration with extensive pre-existing geographic atrophy of the retinal pigment epithelium.
Autor:
Neal S. Kleiman, Aviv Mager, Milton Roller, Alexander Battler, Alejandro Solodky, Ran Kornowski, Abid Assali, David Brosh, Eli I. Lev, Naama Harel
Publikováno v:
Journal of the American College of Cardiology. 55(2):114-121
Objectives The aim of this study was to evaluate whether addition of omega-3 fatty acids or increase in aspirin dose improves response to low-dose aspirin among patients who are aspirin resistant. Background Low response to aspirin has been associate
Autor:
M, Sieber, H, Tesch, B, Pfistner, U, Rueffer, U, Paulus, R, Munker, R, Hermann, G, Doelken, P, Koch, J, Oertel, S, Roller, P, Worst, H, Bischof, A, Glunz, R, Greil, K, von Kalle, K P, Schalk, D, Hasenclever, O, Brosteanu, E, Duehmke, A, Georgii, A, Engert, M, Loeffler, V, Diehl, R P, Mueller, N, Willich, R, Fischer, M L, Hansmann, H, Stein, T, Schober, B, Koch
Publikováno v:
Annals of Oncology. 15:276-282
Background: The purpose of this study was to compare the efficacy of the hybrid chemotherapeutic regimen COPP/ABV/IMEP (cyclophosphamide–vincristine–procarbazine–prednisone–doxorubicin–bleomycin–vinblastine–ifosfamide–methotrexate–e
Publikováno v:
Journal of Trauma and Acute Care Surgery. 51:518-521
Little information is available concerning dosage and optimal initiation of thromboprophylactic therapy with low-molecular-weight heparin (enoxaparin) in nonelective hip surgery. The aim of our prospective study was to evaluate the incidence of clini
Autor:
Ernst Pilger, Veronica A. Carroll, Regina E. Roller, Johann Wojta, Bernd R. Binder, Sandra Janisch, Erich Kvas
Publikováno v:
Thrombosis Research. 94:241-247
We have investigated fibrinolytic parameters in 33 patients with peripheral arterial occlusive disease (PAOD) before and 6, 24, and 48 hours after percutaneous transluminal angioplasty (PTA) as well as in 35 gender-matched healthy controls, whose mea
Autor:
P Swift, L. Borgström, QA Summers, C MacEarlan, P. N. Le Souëf, Mark L. Everard, C M Roller, Sunalene G. Devadason
Publikováno v:
European Respiratory Journal. 10:2023-2028
Drug delivery to patients using dry powder inhalers, such as the Turbuhaler, is believed to be influenced by the inspiratory flow used. Clinical studies have indicated that this delivery system can be used effectively by children. However, it is not
Autor:
Mathias J, Rummel, Norbert, Niederle, Georg, Maschmeyer, G Andre, Banat, Ulrich, von Grünhagen, Christoph, Losem, Dorothea, Kofahl-Krause, Gerhard, Heil, Manfred, Welslau, Christina, Balser, Ulrich, Kaiser, Eckhart, Weidmann, Heinz, Dürk, Harald, Ballo, Martina, Stauch, Fritz, Roller, Juergen, Barth, Dieter, Hoelzer, Axel, Hinke, Wolfram, Brugger, J, Zimber
Publikováno v:
Lancet (London, England). 381(9873)
Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of care for patients with advanced indolent lymphoma, and for elderly patients with mantle-cell lymphoma. Bendamusti
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 13(4)
We have used the platelet analyzer PFA-100TM to assess the effect of aspirin (ASA) in patients with documented peripheral arterial disease (PAD). Thirty-one previously untreated patients were recruited. Laboratory investigations, including the collag
Autor:
Norbert Niederle, Heinz A. Duerk, Martina Stauch, Christina Balser, Axel Hinke, Chrisoph Losem, G.-Andre Banat, Mathias J. Rummel, Manfred Welslau, Ulrich von Grünhagen, Harald Ballo, Wolfram Brugger, Eckhart Weidmann, Juergen Barth, Dorothea Kofahl-Krause, Fritz Roller, Gerhard Heil, Alexander Burchardt, Georg Maschmeyer, Ulrich Kaiser
Publikováno v:
Blood. 120:2724-2724
Abstract 2724 Background: The NHL 1 study, a prospective, multicenter, randomized, phase 3 study which compared B-R and CHOP-R as first-line treatment in indolent lymphomas and mantle cell lymphoma (MCL), demonstrated a significant benefit in progres
Autor:
Dorothea Kofahl-Krause, Georg Maschmeyer, Wolfram Brugger, Juergen Barth, Lars Fischer, Mathias J. Rummel, Christoph Alexander Burchardt, Fritz Roller
Publikováno v:
Blood. 114:2679-2679
Abstract 2679 Poster Board II-655 Introduction: Bendamustine, a hybrid alkylating agent, shows a unique mechanism of action with a good toxicity profile in various hematological malignancies, particularly in non-Hodgkin's lymphoma. Bendamustine (B) i